Pharmaceutical Benefits Advisory Committee Guidelines Review
Page last updated: 6 May 2016
The public consultation processes on the draft revised PBAC Guidelines (Version 5.0) and the assessment of co-dependent technology chapter closed on 5 April 2016 and 11 April 2016 respectively. The Department appreciates the contribution of all organisations and individuals who made a submission.
The submissions are now available from the public consultation webpage for the draft revised PBAC Guidelines and the public consultation webpage for the draft assessment of co dependent technology chapter.
The submissions have been provided to the Guidelines Review Steering Committee for consideration in the finalisation of the revised PBAC Guidelines.